ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0450 (10.00%)
At close: May 6, 2026
ZYUS Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 0.47 | 0.48 | 0.35 | 0.3 | - | 0 | |
Revenue Growth (YoY) | 2.88% | 37.04% | 17.79% | - | - | -38.56% |
Cost of Revenue | 0.24 | 0.21 | 0.15 | 0.1 | - | -0 |
Gross Profit | 0.06 | 0.13 | 0.17 | -0.23 | - | 0 |
Selling, General & Admin | 7.96 | 8.67 | 12.01 | 8.68 | - | - |
Depreciation & Amortization Expenses | 2.89 | 2.96 | 3.11 | 4.05 | - | - |
Research & Development | 2.04 | 2.05 | 1.31 | 2.21 | - | - |
Other Operating Expenses | 0.96 | 21.59 | 27.88 | 4.05 | - | - |
Total Operating Expenses | 13.85 | 35.27 | 44.31 | 18.99 | 0 | 0 |
Operating Income | -33.92 | -34.99 | -42.14 | -18.79 | - | 0 |
Interest Income | 0.46 | - | - | - | 0.58 | -0.52 |
Interest Expense | -1.94 | -1.08 | -3.85 | -5.46 | - | - |
Other Non-Operating Income (Expense) | -1.25 | -0.35 | -1.9 | -6.81 | - | - |
Total Non-Operating Income (Expense) | -2.74 | -1.43 | -5.74 | -12.28 | 0.58 | -0.52 |
Pretax Income | -35.78 | -35.89 | -48.44 | -24.72 | 0.35 | -0.73 |
Provision for Income Taxes | -2.04 | -2.09 | -5.85 | -0.06 | - | - |
Net Income | -33.74 | -33.81 | -42.59 | -24.66 | 0.35 | -0.73 |
Net Income to Common | -33.74 | -33.81 | -42.59 | -24.66 | 0.35 | -0.73 |
Shares Outstanding (Basic) | 76 | 72 | 56 | 38 | 5 | 5 |
Shares Outstanding (Diluted) | 76 | 72 | 56 | 38 | 5 | 5 |
Shares Change (YoY) | 6.47% | 28.41% | 45.82% | 665.26% | - | - |
EPS (Basic) | -0.46 | -0.47 | -0.76 | -0.64 | 0.07 | -0.14 |
EPS (Diluted) | -0.46 | -0.47 | -0.76 | -0.64 | 0.07 | -0.14 |
Shares Outstanding | 78.15 | 74.36 | 70.85 | 38.53 | 4.89 | 4.89 |
Free Cash Flow | -12.61 | -9.92 | -18.23 | -10.13 | -0.33 | -0.02 |
Free Cash Flow Per Share | -0.17 | -0.14 | -0.32 | -0.26 | -0.07 | -0.00 |
Gross Margin | 13.12% | 26.82% | 48.72% | -77.85% | - | 257.09% |
Operating Margin | -7295.27% | -7274.84% | -12006.00% | -6306.04% | - | 257.09% |
Profit Margin | -7256.77% | -7028.07% | -12134.20% | -8274.16% | - | -294932.00% |
FCF Margin | -2712.47% | -2062.79% | -5193.45% | -3400.67% | - | -8779.35% |
EBITDA | -31.04 | -32.03 | -39.04 | -14.75 | 0 | 0 |
EBITDA Margin | -6674.84% | -6659.25% | -11121.10% | -4948.66% | - | 257.09% |
EBIT | -33.92 | -34.99 | -42.14 | -18.79 | - | 0 |
EBIT Margin | -7295.27% | -7274.84% | -12006.00% | -6306.04% | - | 257.09% |
Effective Tax Rate | 5.69% | 5.82% | 12.07% | 0.23% | 0.00% | 0.00% |